Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions

Nature volume 491, pages 264–268 (2012)Cite this article

Subjects

Abstract

B cells regulate immune responses by producing antigen-specific antibodies1. However, specific B-cell subsets can also negatively regulate T-cell immune responses, and have been termed regulatory B cells2,3,4. Human and mouse regulatory B cells (B10 cells) with the ability to express the inhibitory cytokine interleukin-10 (IL-10) have been identified2,3,4,5. Although rare, B10 cells are potent negative regulators of antigen-specific inflammation and T-cell-dependent autoimmune diseases in mice5,6,7. How B10-cell IL-10 production and regulation of antigen-specific immune responses are controlled in vivo without inducing systemic immunosuppression is unknown. Using a mouse model for multiple sclerosis, here we show that B10-cell maturation into functional IL-10-secreting effector cells that inhibit in vivo autoimmune disease requires IL-21 and CD40-dependent cognate interactions with T cells. Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease. The ex vivo expansion and reinfusion of autologous B10 cells may provide a novel and effective in vivo treatment for severe autoimmune diseases that are resistant to current therapies.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: IL-21 induces regulatory B10-cell function.
Figure 2: B10 cells require IL-10, IL-21R, CD40 and MHC-II expression to regulate EAE severity.
Figure 3: B10-cell expansion and regulation of T-cell-mediated autoimmunity.
Figure 4: IL-21 drives ex vivo regulatory B10-cell expansion.

References

  1. LeBien, T. W. & Tedder, T. F. B-lymphocytes: how they develop and function. Blood 112, 1570–1580 (2008)

    Article  CAS  Google Scholar 

  2. DiLillo, D. J., Matsushita, T. & Tedder, T. F. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. NY Acad. Sci. 1183, 38–57 (2010)

    Article  ADS  CAS  Google Scholar 

  3. Fillatreau, S. Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection. Immunol. Rev. 240, 52–71 (2011)

    Article  CAS  Google Scholar 

  4. Mauri, C. Regulation of immunity and autoimmunity by B cells. Curr. Opin. Immunol. 22, 761–767 (2010)

    Article  CAS  Google Scholar 

  5. Iwata, Y. et al. Characterization of a rare IL-10-competent B cell subset in humans that parallels mouse regulatory B10 cells. Blood 117, 530–541 (2011)

    Article  CAS  Google Scholar 

  6. Yanaba, K. et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28, 639–650 (2008)

    Article  CAS  Google Scholar 

  7. Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M. & Tedder, T. F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118, 3420–3430 (2008)

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Ray, A., Basu, S., Williams, C. B., Salzman, N. H. & Dittel, B. N. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J. Immunol. 188, 3188–3198 (2012)

    Article  CAS  Google Scholar 

  9. Yanaba, K., Bouaziz, J.-D., Matsushita, T., Tsubata, T. & Tedder, T. F. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 182, 7459–7472 (2009)

    Article  CAS  Google Scholar 

  10. Haas, K. M. et al. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J. Immunol. 184, 4789–4800 (2010)

    Article  CAS  Google Scholar 

  11. Matsushita, T., Horikawa, M., Iwata, Y. & Tedder, T. F. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling EAE initiation and late-phase immunopathogenesis. J. Immunol. 185, 2240–2252 (2010)

    Article  CAS  Google Scholar 

  12. Horikawa, M., Minard-Colin, V., Matsushita, T. & Tedder, T. F. Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J. Clin. Invest. 121, 4268–4280 (2011)

    Article  CAS  Google Scholar 

  13. Maseda, D. et al. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J. Immunol. 188, 1036–1048 (2012)

    Article  CAS  Google Scholar 

  14. Spolski, R. & Leonard, W. J. IL-21 and T follicular helper cells. Int. Immunol. 22, 7–12 (2009)

    Article  Google Scholar 

  15. Linterman, M. A. & Vinuesa, C. G. T follicular helper cells during immunity and tolerance. Prog. Mol. Biol. Transl. Sci. 92, 207–248 (2010)

    Article  CAS  Google Scholar 

  16. Ettinger, R. et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175, 7867–7879 (2005)

    Article  CAS  Google Scholar 

  17. Ozaki, K. et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173, 5361–5371 (2004)

    Article  CAS  Google Scholar 

  18. Ozaki, K. et al. A critical role for IL-21 in regulating immunoglobulin production. Science 298, 1630–1634 (2002)

    Article  ADS  CAS  Google Scholar 

  19. Spolski, R., Kim, H. P., Zhu, W., Levy, D. E. & Leonard, W. J. IL-21 mediates suppressive effects via its induction of IL-10. J. Immunol. 182, 2859–2867 (2009)

    Article  CAS  Google Scholar 

  20. Pot, C. et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183, 797–801 (2009)

    Article  CAS  Google Scholar 

  21. Bettelli, E. et al. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073–1081 (2003)

    Article  CAS  Google Scholar 

  22. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006)

    Article  ADS  CAS  Google Scholar 

  23. Chen, G. et al. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel. J. Immunol. 185, 2350–2359 (2010)

    Article  CAS  Google Scholar 

  24. Poe, J. C. et al. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS ONE 6, e22464 (2011)

    Article  ADS  CAS  Google Scholar 

  25. Nojima, T. et al. In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo. Nature Comm. 2, 465 (2011)

    Article  ADS  Google Scholar 

  26. Goodnow, C. C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676–682 (1988)

    Article  ADS  CAS  Google Scholar 

  27. Coquet, J. M., Chakravarti, S., Smyth, M. J. & Godfrey, D. I. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 180, 7097–7101 (2008)

    Article  CAS  Google Scholar 

  28. Hoehlig, K. et al. Activation of CD4+ Foxp3+ regulatory T cells proceeds normally in the absence of B cells during EAE. Eur. J. Immunol. 42, 1164–1173 (2012)

    Article  CAS  Google Scholar 

  29. Weber, M. S. et al. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nature Med. 13, 935–943 (2007)

    Article  CAS  Google Scholar 

  30. Matsushita, T. & Tedder, T. F. Identifying regulatory B cells (B10 cells) that produce IL-10. Methods Mol. Biol. 677, 99–111 (2011)

    Article  CAS  Google Scholar 

  31. Kühn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263–274 (1993)

    Article  Google Scholar 

  32. Grusby, M. J. et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl Acad. Sci. USA 90, 3913–3917 (1993)

    Article  ADS  CAS  Google Scholar 

  33. Sato, S., Ono, N., Steeber, D. A., Pisetsky, D. S. & Tedder, T. F. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157, 4371–4378 (1996)

    CAS  PubMed  Google Scholar 

  34. Sato, S., Steeber, D. A., Jansen, P. J. & Tedder, T. F. CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19. J. Immunol. 158, 4662–4669 (1997)

    CAS  PubMed  Google Scholar 

  35. Zhou, L.-J. et al. Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B lymphocyte development. Mol. Cell. Biol. 14, 3884–3894 (1994)

    Article  CAS  Google Scholar 

  36. Tedder, T. F., Wagner, N. & Engel, P. in Leukocyte Typing V: White Cell Differentiation Antigens Vol. 1 (eds Schlossman, S. F. et al.) 483–504 (Oxford Univ. Press, 1995)

    Google Scholar 

  37. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. & Anderton, S. M. B cells regulate autoimmunity by provision of IL-10. Nature Immunol. 3, 944–950 (2002)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank D. Maseda, E. Weimer, J. Bryant, K. Candando and G. Venturi for help and comments. These studies were supported by grants from the National Institutes of Health (NIH; AI56363 and AI057157), the Lymphoma Research Foundation, and the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH.

Author information

Author notes

  1. Ayumi Yoshizaki, Tomomitsu Miyagaki and Thomas F. Tedder: These authors contributed equally to this work.

Authors and Affiliations

  1. Departments of Immunology, Duke University Medical Center, Durham, 27710, North Carolina, USA

    Ayumi Yoshizaki, Tomomitsu Miyagaki, David J. DiLillo, Takashi Matsushita, Mayuka Horikawa, Evgueni I. Kountikov, Jonathan C. Poe & Thomas F. Tedder

  2. Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, 20892-1674, Maryland, USA

    Rosanne Spolski & Warren J. Leonard

Authors
  1. Ayumi Yoshizaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomomitsu Miyagaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David J. DiLillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Matsushita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mayuka Horikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Evgueni I. Kountikov
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rosanne Spolski
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jonathan C. Poe
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Warren J. Leonard
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Thomas F. Tedder
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

A.Y., T.Mi., D.J.D., T.Ma., M.H., J.C.P., W.J.L. and T.F.T. conceived and designed the studies. A.Y., T.Mi., D.J.D., T.Ma., M.H., E.I.K., R.S., J.C.P. and W.J.L. carried out or contributed essential reagents and materials for the experiments. All authors contributed to data analysis and manuscript preparation.

Corresponding author

Correspondence to Thomas F. Tedder.

Ethics declarations

Competing interests

T.F.T. is a consultant and shareholder for Angelica Therapeutics, Inc. R.S. and W.J.L. are inventors on patents and patent applications related to IL-21. The other authors have no financial conflicts of interest.

Supplementary information

Supplementary Figures

This file contains Supplementary Figures 1-2. (PDF 266 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yoshizaki, A., Miyagaki, T., DiLillo, D. et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491, 264–268 (2012). https://doi.org/10.1038/nature11501

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature11501

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing